Trial · NCT00217737
Participant flow40
How many started, completed or left each group, period by period.
1 to 20 of 40
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Step 1 Registration (Risk Assessment) | STARTED | Arm A (5-FU, Leucovorin, Oxaliplatin) | 460 | |
| Step 1 Registration (Risk Assessment) | STARTED | Arm B (5-FU, Leucovorin, Oxaliplatin, Bevacizumab) | 458 | |
| Step 1 Registration (Risk Assessment) | STARTED | Arm C (Observation) | 1,013 | |
| Step 1 Registration (Risk Assessment) | STARTED | No Randomization/Registration at Step 2 | 500 | |
| Step 1 Registration (Risk Assessment) | COMPLETED | Arm A (5-FU, Leucovorin, Oxaliplatin) | 460 | |
| Step 1 Registration (Risk Assessment) | COMPLETED | Arm B (5-FU, Leucovorin, Oxaliplatin, Bevacizumab) | 458 | |
| Step 1 Registration (Risk Assessment) | COMPLETED | Arm C (Observation) | 1,013 | |
| Step 1 Registration (Risk Assessment) | COMPLETED | No Randomization/Registration at Step 2 | 0 | |
| Step 1 Registration (Risk Assessment) | NOT COMPLETED | Arm A (5-FU, Leucovorin, Oxaliplatin) | 0 | |
| Step 1 Registration (Risk Assessment) | NOT COMPLETED | Arm B (5-FU, Leucovorin, Oxaliplatin, Bevacizumab) | 0 | |
| Step 1 Registration (Risk Assessment) | NOT COMPLETED | Arm C (Observation) | 0 | |
| Step 1 Registration (Risk Assessment) | NOT COMPLETED | No Randomization/Registration at Step 2 | 500 | |
| Step 2 Randomization/Registration | STARTED | Arm A (5-FU, Leucovorin, Oxaliplatin) | 460 | |
| Step 2 Randomization/Registration | STARTED | Arm B (5-FU, Leucovorin, Oxaliplatin, Bevacizumab) | 458 | |
| Step 2 Randomization/Registration | STARTED | Arm C (Observation) | 1,013 | |
| Step 2 Randomization/Registration | STARTED | No Randomization/Registration at Step 2 | 0 | |
| Step 2 Randomization/Registration | Eligible Patients | Arm A (5-FU, Leucovorin, Oxaliplatin) | 424 | |
| Step 2 Randomization/Registration | Eligible Patients | Arm B (5-FU, Leucovorin, Oxaliplatin, Bevacizumab) | 435 | |
| Step 2 Randomization/Registration | Eligible Patients | Arm C (Observation) | 998 | |
| Step 2 Randomization/Registration | Eligible Patients | No Randomization/Registration at Step 2 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00217737/flow